Learn more about HHSC’s collaboration with AbbVie to combat Hepatitis C in Medicaid.
A drug must meet all four of the rule criteria to be considered for inclusion on the HHSC specialty drug list (SDL). The SDL includes drugs MCOs may exclusively provide through their specialty pharmacy network.
An update to the Clinical Prior Authorization Assistance Chart is available. The chart is a quarterly update identifying the clinical prior authorizations each MCO uses and how those relate to those used for traditional Medicaid claim processing.
The Texas Drug Utilization Review Board met recently to make recommendations about clinical prior authorizations.